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Abstract
Background: Declines in bone, muscle and physical performance are associated with adverse health outcomes in
older adults. However, few studies have described concurrent age-related patterns of change in these factors. The
purpose of this study was to characterize change in four properties of muscle, physical performance, and bone in a
prospective cohort study of older men.
Methods: Using repeated longitudinal data from up to four visits across 6.9 years from up to 4681 men (mean age
at baseline 72.7 yrs. ±5.3) participating in the Osteoporotic Fractures in Men (MrOS) Study, we used group-based
trajectory models (PROC TRAJ in SAS) to identify age-related patterns of change in four properties of muscle,
physical performance, and bone: total hip bone mineral (BMD) density (g/m2) and appendicular lean mass/ht2 (kg/
m2), by DXA; grip strength (kg), by hand dynamometry; and walking speed (m/s), by usual walking pace over 6 m.
We also described joint trajectories in all pair-wise combinations of these measures. Mean posterior probabilities of
placement in each trajectory (or joint membership in latent groups) were used to assess internal reliability of the
model. The number of trajectories for each individual factor was limited to three, to ensure that the pair-wise
determination of joint trajectories would yield a tractable number of groups as well as model fit considerations.
Results: The patterns of change identified were generally similar for all measures, with three district groups
declining over time at roughly similar rates; joint trajectories revealed similar patterns with no cross-over or
convergence between groups. Mean posterior probabilities for all trajectories were similar and consistently above
0.8 indicating reasonable model fit to the data.
Conclusions: Our description of trajectories of change with age in bone mineral density, grip strength, walking
speed and appendicular lean mass found that groups identified by these methods appeared to have little crossover
or convergence of change with age, even when considering joint trajectories of change in these factors.
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Background
Poor physical performance is a harbinger of mortality
[1], and it is strongly associated with age-related morbid-
ity, including mobility limitations, falls, fractures,
hospitalization, dependency, and long-term care [2–9].
In addition, osteoporosis and sarcopenia are important
contributors to age-related declines in performance. Low
bone mass can result in fractures, and in turn to both
short- and long-term disability and functional depend-
ence [10–12]. Sarcopenia (age-related muscle loss that is
accompanied by reduced strength and physical perform-
ance) [13] Sarcopenia (age-disability and dependence.
Although change in bone, muscle and physical perform-
ance may be associated with unfavorable outcomes (such
falls, fractures, mortality and disability) [14–17], few
studies have investigated the process of change in these
factors concurrently.
In older men, we have described distinct trajectories of
bone loss with age, demonstrating that the character of
change is important, and that declines increases fracture
risk and mortality [2, 14]. However, we have not exten-
sively characterized change in muscle and physical per-
formance. There is a gap in the literature with regard to
characterization of change in several musculoskeletal
factors concurrently: few, if any, papers have been pub-
lished in this area. Studies that have reported change in
measures simultaneously tend to report change in just
two factors rather than a set of musculoskeletal variables
[18, 19]. Muscle and bone are both generated from cells
differentiated from mesenchymal stem cells, and as a re-
sult have overlapping genetic and biological underpin-
nings [20], that represents a closely linked “complex” in
both biology and function. Thus, our ultimate goal is to
test the hypothesis that when age-related deterioration
in bone, muscle and physical performance occur in par-
allel their combined effects magnify the risk of poor
functional and health outcomes among community-
dwelling older men.
To quantify the trajectories, grip strength and walking
speed were included for the physical performance/
strength domain, because these measures are included in
most of the consensus definitions of sarcopenia [21–23],
and each have been consistently associated with poor out-
comes such as mortality and disability in older adults [24,
25]. To quantify change in muscle, we used an approxima-
tion of muscle mass, appendicular lean body standardized
to height squared (ALM/ht2) [26]. Total hip BMD was
used as the measure of bone mineral density.
This report identifies joint and individual trajectory
patterns in these musculoskeletal factors using data from
the Osteoporotic Fractures in Men (MrOS) study, a pro-
spective cohort study of older, community-dwelling men
in order to provide a descriptive summary of how these
factors concurrently change with age. We expected that
we would identify subsets of men who had markedly
rapid declines in these musculoskeletal factors, both in-
dividually and in combination.
Methods
The MrOS Study has been previously described [27, 28].
Briefly, between March 2000 and April 2002, 5994
community-dwelling, ambulatory men age ≥ 65 years free
from bilateral hip replacement were recruited to partici-
pate at six United States clinical centers (Birmingham,
Alabama; Minneapolis, Minnesota; Palo Alto, California;
Monongahela Valley near Pittsburgh, Pennsylvania; Port-
land, Oregon; and San Diego, California). All surviving
participants were invited to return to the clinic for the
Year 5 visit (Visit 2, March 2005–May 2006; N at visit,
5229) and the Year 7 visit (Visit 3, March 2007–March
2009; N at visit, 4681). A subset of participants were in-
vited to an ancillary Year 3.5 Visit (Sleep Visit, Decem-
ber 2003–March 2005) designed to understand sleep
habits of older men (N at visit =3153). Institutional re-
view boards at all clinic centers and the San Francisco
Coordinating Center (University of California, San Fran-
cisco and California Pacific Medical Center Research In-
stitute) approved this study, and all men provided
written informed consent at each study visit. Protocols
were standardized across all visits unless otherwise
noted; at each contact, all measures were completed dur-
ing a single visit on the same day.
Walking speed and grip strength
Physical performance was assessed at baseline and the
Years 3.5, 5 and 7 visits [9]. Walking speed (m/s) was
taken as the average of two trials over six meters at the
participant’s usual pace. Grip strength was measured
using Jamar dynamometers (Sammons Preston Rolyan,
Bolingbrook, IL, USA), and the maximum effort from
two trials of both hands was analyzed [29].
Lean mass and bone mineral density
Total hip bone mineral density (BMD) and appen-
dicular lean mass (ALM) were measured using Holo-
gic 4500 dual energy x-ray absorptiometry (DXA)
machines; the maximum percent difference between
scanners was 1.2%. DXA scans were analyzed at each
clinical center, with a centralized review of a random
subset of scans and all problematic scans identified by
technicians at the clinics. The primary measure of
lean mass was ALM/ht2 (kg/m2).
Other measures
Height was measured on wall-mounted Harpenden sta-
diometers (Holtain Ltd., Dyved, United Kingdom) and
weight on balance beam or digital scales with standard-
ized protocols. Body mass index (BMI) was calculated as
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weight (kg) / height2 (m2). Activity level was determined
from the Physical Activity Scale for the Elderly (PASE)
[30], a unit less measure where higher scores indicated a
higher activity level. Self-rated health was classified as
excellent/good (compared to fair/poor/very poor). Med-
ical conditions included self-report of a physician’s diag-
nosis of the following: diabetes, stroke, myocardial
infarction, non-skin cancer, high blood pressure, con-
gestive heart failure, and Parkinson’s disease and were
analyzed as the presence of one or more (vs. none).
Functional limitations were assessed by self-report of at
least some difficulty with any of the following tasks:
walking 2–3 blocks, climbing stairs, shopping, cooking
meals and heavy housework.
Analysis subset
Men were included in the analyses if they had values for
the main musculoskeletal measurements (walking speed,
grip strength, ALM/ht2, and total hip BMD) at baseline
and the Year 7 visit (Visit 3). We restricted the sample
to this population because the ultimate goal is to deter-
mine whether trajectories up to the Year 7 predict out-
comes subsequent to that visit. When available, Year 3.5
and Year 5 data was also used to determine the trajec-
tories. Of the 5994 men at baseline, 1313 did not attend
any part of the Year 7 visit: 1043 died before the visit;
101 were living but declined participation and 169 ter-
minated participation in the study before the visit. At
Year 7, 4681 men provided at least some data (including
those who were classified as unable) for grip strength,
walking speed, total hip BMD or ALM/ht2.
Modeling of trajectories
First, these analyses described trajectories of each of four
factors individually: grip strength, ALM/ht2, total hip
BMD, and walking speed.
Second, we describe the joint trajectories in all pair-
wise combinations of these factors (that is, concurrent
change in grip strength-ALM/ht2; grip strength-total hip
BMD; grip strength-walking speed; ALM/ht2-total hip
BMD; ALM/ht2-walking speed; and total hip BMD-
walking speed.)
We used group based trajectory modeling (GBTM)
to identify patterns of change in these factors with
the TRAJ procedure in SAS which identifies clusters
of individuals following similar progressions of a spe-
cified phenotype over some measure of time (in our
case, age) [31, 32].
A priori, we decided to limit the number of trajectories
for each individual factor to three, to ensure that the
pair-wise determination of joint trajectories would yield
a tractable number of groups. Thus, using 3 trajectories
for two individual factors results in 9 joint trajectories.
An individual was assigned to a group based on his
highest posterior group probability over the change
period. Using the final model as described above, we cal-
culated mean posterior probabilities of placement in
each trajectory (i.e., joint membership in latent groups)
to assess internal reliability of the model. Patterns of
change for each individual and joint membership in la-
tent groups were depicted graphically. We tested
whether characteristics of participants differed by the
joint trajectory membership assigned, using ANOVA for
normal continuous variables, Kruskal-Wallis for skewed
continuous variables, and chi-square tests for categorical
variables. Change in each factor was plotted graphically
using a spline plot for the actual value of the factor from
the single trajectory model for each age group. Similarly
for joint trajectories, the actual value for each age and
joint trajectory was calculated and plotted using a spline
fit after group assignment was determined [33]. Al-
though the determination of trajectories was determined
jointly for each pairwise comparison (e.g. grip strength
and BMD together), we show graphically trajectories of
grip strength by category of BMD trajectory (and vice
versa). A three-way graphical description of the data
(grip trajectory vs BMD trajectory vs age) was too
unwieldly.
Missing data or unable to complete a measure
Men who did not have values for the performance-based
tests (walking speed and grip strength) at any visit be-
cause they attempted but were considered unable to do
the measure for physical reasons (per study staff or per-
sonal assessment) were not included in the trajectories
analyses. These men were included as a separate group
in the characteristics table. Men who had missing values
for the performance measures or the DXA measures for
other reasons (for example, “questionnaire only” partici-
pants without a clinic visit) were included in the trajec-
tories analyses with the appropriate value set to missing.
Of the 4681 men at the Year 5 visit, 259 men were un-
able to complete the grip strength exam at all visits; 18
were unable to complete the walking test at all visits. In
addition, one had missing total hip BMD at all visits,
and 14 were missing ALM/ht2 data at all visits. Thus,
the N for each classification of trajectories in each meas-
ure was 4681 for grip strength (4422 with a trajectory
calculated and 259 unable to complete at all visits who
were included as a separate group); 4680 for walking
speed (includes 4662 with a trajectory calculated and 18
who were unable to complete at all visits who were in-
cluded as a separate group); 4680 for total hip BMD and
4667 for ALM/ht2. Men missing values at all visits were
excluded from the individual and pair-wise joint trajec-
tories as appropriate. (Additional file 1).
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Results
Men in the MrOS cohort, and the analytic sample for
this report, were relatively healthy with a mean age of
72.7 years (Table 1). The individual factor trajectories
(for ALM/ht2, grip strength, walking speed and total hip
BMD separately) are presented in Fig. 1. In general, the
patterns identified are roughly similar for each factor:
there appears to be decline in each trajectory with age,
and there is no-cross over or convergence in the rate of
change with age. Based on this descriptive information,
we describe each factor to have three trajectories: “low”,
“intermediate”, and “high”.
As an illustrative example, the joint trajectories for total
hip BMD and grip strength are shown in Fig. 2. In panel
A, the trajectories for grip strength are shown for partici-
pants within the low BMD trajectory, the medium BMD
trajectory and the high BMD trajectory. Some of the
groups identified were rather small: only 159 men (3.6% of
the total men in the model) were in the high BMD/low
grip strength trajectory and only 179 men (4.0% of the
total men in the model) were in the high BMD/high grip
strength group; the most common placement was in the
medium BMD/medium grip strength trajectory (N = 1127,
25.4% of the total men in the model). Figure 2, Panel B
shows the trajectories in BMD across the low, medium
and high grip strength groups. Differences in participant
characteristics by the joint grip strength/BMD trajectory
group are reported in Table 2. As expected, there are large
differences in grip strength and BMD by the joint grip
strength/BMD trajectory groups. In addition, aside from
age, all of the other factors reported in Table 2 differed by
joint grip strength/BMD trajectory group. Generally, those
in the high grip strength trajectory groups, regardless of
the BMD trajectory group, appeared to have the most fa-
vorable characteristics (e.g. fastest walking speed, higher
physical activity, fewest ADL limitations).
Additional files 2, 3, 4, 5 and 6 show the joint trajec-
tories for the other pair-wise trajectories examined, and
characteristics of participants are reported for each pair-
wise trajectory group in Additional file 7. Overall, char-
acteristics of participants varied by trajectory placement,
although this appeared somewhat less pronounced with
some non-significant differences for the ALM/ht2 and
BMD joint trajectories.
Mean posterior probabilities, i.e. the mean of the prob-
ability of being assigned to trajectory based on the par-
ticipant’s given data points, were reasonably high,
ranging from 0.84–0.89, suggesting that most partici-
pants’ actual trajectory fit the modeled trajectory reason-
ably well.
Discussion
We characterized patterns of change in bone density,
strength, walking speed and appendicular lean mass. In
contrast to our initial hypothesis that these analyses
would reveal discrete categories of men with rapid de-
cline in one or a combination of these musculoskeletal
phenotypes, our results did not demonstrate such sub-
groups. In fact, the three groups of change characterized
by the analysis (“high”, “medium”, and” low”) appeared
to have little crossover or convergence of change with
age, even when considering joint trajectories of change
in these factors. The trajectory groups were associated
with significant differences in other non-trajectory par-
ticipant characteristics, although this was less pro-
nounced for the ALM/ht2 and BMD joint trajectories
than for the other individual and joint trajectories. Sev-
eral other studies have examined changes in lean mass
and muscle strength that occurs with older age in men
[19, 34, 35] while some other reports have evaluated
change in performance, lean mass, and bone density.
However, few studies have sought to systematically
Table 1 Baseline characteristics (mean ± SD or N(%)) by inclusion in the analysis subset
Analytic sample
N = 4681
Not included in analytic sample
N = 1313
p-value
Age (years) 72.7 ± 5.3 77 ± 6.5 < 0.0001
Walking speed (m/s) 1.23 ± 0.2 1.09 ± 0.25 < 0.0001
Grip strength (kg) 42.7 ± 8.2 37.6 ± 8.4 < 0.0001
PASE 151.7 ± 67.3 127.8 ± 68.4 < 0.0001
Total Hip BMD (g/cm2) 0.963 ± 0.14 0.939 ± 0.149 < 0.0001
Excellent/good health 4140 (88.4) 995 (75.9) < 0.0001
One or more functional limitationa 769 (16.4) 465 (35.4) < 0.0001
BMI (kg/m2) 27.4 ± 3.7 27.2 ± 4.1 0.0474
One or more medical conditionsb 2825 (60.4) 973 (74.1) < 0.0001
ALM/ht2 (kg/m2) 8.03 ± 0.9 7.79 ± 1.02 < 0.0001
aFunctional limitations include: walking 2–3 blocks, climbing stairs, shopping, cooking meals and heavy housework
bOne or more of the following: diabetes, stroke, myocardial infarction, non-skin cancer, high blood pressure, congestive heart failure and Parkinson’s disease
PASEPhysical Activity Scale for the Elderly, BMD bone mineral density, BMI body mass index, ALM appendicular lean mass
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identify concurrent patterns in change in these factors over
time. We also found that men in low trajectories in one
area tended to be in the low trajectories in another area
(e.g. those in the low BMD trajectory tended to be in the
low grip strength trajectory). Examining characteristic of
men by trajectory group, men in low trajectories tended to
have worse health status and more co-morbidities than
those in the higher trajectories. It is possible that placement
in the lower trajectories reflects less successful aging.
Unlike other analyses that have used a similar group-
based trajectory modeling approach [36], we did not iden-
tify groups in which change appeared to cross-over or
converge with age; nor were subsets of rapid change evi-
dent. Across the factors, the patterns of change identified
were generally similar, with three groups declining over
time at apparently comparable rates, although we did not
formally test all pairwise difference between groups. This
may be due to the fact that the components of the trajec-
tories were only measured at three time points, which
would limit our ability to see such non-linear change, such
as rapid decline that might occur near the end of life or as
a result of an acute illness or hospitalization. In addition,
many other trajectory analyses are anchored to a specific
event, such as change in disability patterns preceding
death. In contrast, our data simply describes the decline in
these factors with general aging rather than in response to
acute events. Participants in MrOS were generally healthy
at baseline and because the assessments used in the trajec-
tory modeling were completed in men who returned to
the clinic. Our data may also represent the healthiest sub-
set of participants and underestimate trajectories that
would be seen in more frail or sick men. The results of
this study were somewhat surprising.
Our study used a data driven approach to find patterns
of change in a large well characterized cohort of older
men. This study provides a key descriptive background of
possible categories of bone-muscle phenotypes. However,
a number of limitations must be noted. First, the trajec-
tory models are descriptive in nature and do not specific-
ally test for different rates of change (e.g. slopes) or initial
or ending values when determining group membership.
This limits our ability to evaluate differences between tra-
jectories unless we specifically test those differences post-
hoc. Second, the posterior probabilities for trajectory
placement were reasonably high, although some were
closer to .8 suggesting that other models may more
Fig. 1 Individual trajectories in grip strength, walking speed, total hip BMD and ALM/ht2 in older men
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accurately reflect underlying patterns in the data, especially
for very small subgroups. However, some joint trajectory
groups had a non-trivial number of men with a relatively
low probability of group membership (< 50%), suggesting
that these method did not identify distinct trajectories that
were followed by a small minority of men. Third, we have
not tested whether these trajectories predict adverse health
outcomes, nor whether any such associations are independ-
ent of the Year 7 value (that is, whether change per se ver-
sus where the participant ends up is important in
predicting adverse outcomes). Such analyses will be com-
pleted in subsequent reports. Fourth, only an approxima-
tion of muscle mass [37, 38], ALM/ht2, was available at
these MrOS visits. Other approaches that directly measure
muscle mass, such as D3-creatine dilution [39, 40], may re-
sult in different findings. This is likely, as results from ana-
lyses at subsequent MrOS visits found that muscle mass
assessed D3-creatine dilution was strongly related to
physical performance and mobility outcomes, while DXA
ALM/ht2 was not [39]. Finally, our graphical representa-
tions of the trajectories occasionally demonstrated highly
variable patterns of change (for example, Additional file 5).
This is due to small numbers of participants in some ages
in trajectory groups. Larger numbers of participants would
likely makes these trajectories less variable.
Conclusion
Our description of trajectories of change with age in
bone mineral density, grip strength, walking speed and
appendicular lean mass found that groups identified by
these methods appeared to have little crossover or con-
vergence of change with age, even when considering
joint trajectories of change in these factors. Subsequent
studies will evaluate whether trajectories of change pre-
dict subsequent health outcomes including falls, frac-
tures and mortality.
Fig. 2 Joint trajectories in total hip BMD and grip strength in older men
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